Raymond James Financial’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.3K Sell
10,550
-1,000
-9% -$2.11K ﹤0.01% 5483
2025
Q1
$14.1K Hold
11,550
﹤0.01% 4690
2024
Q4
$14.9K Buy
+11,550
New +$14.9K ﹤0.01% 4690